Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen Harvey Zinner, M.D.


This page shows the publications Stephen Zinner has written about Kanamycin.
Connection Strength

  1. Review of amikacin usage in the EORTC trials. Am J Med. 1985 Jul 15; 79(1A):17-20.
    View in: PubMed
    Score: 0.079
  2. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli. Antimicrob Agents Chemother. 1977 Sep; 12(3):349-52.
    View in: PubMed
    Score: 0.046
  3. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli. Antimicrob Agents Chemother. 1976 Apr; 9(4):661-4.
    View in: PubMed
    Score: 0.041
  4. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother. 1986 Feb; 29(2):263-70.
    View in: PubMed
    Score: 0.020
  5. Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group. J Antimicrob Chemother. 1980 Sep; 6 Suppl A:55-61.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.